Synergistic Up-Regulation of Vascular Endothelial Growth Factor (VEGF) Expression in Macrophages by Adenosine A2AReceptor Agonists and Endotoxin Involves Transcriptional Regulation via the Hypoxia Response Element in the VEGF Promoter
Adenosine A2A receptor activators and endotoxin together increase VEGF production in immune cells through low-oxygen response control
AI simplified
Abstract
Adenosine A2A receptor (A2AR) agonists and the TLR4 agonist LPS may synergistically enhance macrophage VEGF expression.
- TLR4 agonist LPS and A2AR agonists NECA and CGS21680 increase VEGF transcription in macrophages.
- The hypoxia response element (HRE) in the VEGF promoter is critical for the transcriptional activation observed.
- LPS treatment raises HIF-1alpha mRNA levels through an NF-kappaB-dependent mechanism, while NECA increases these levels via an A2AR-dependent pathway.
- LPS can induce luciferase expression from a HIF-1alpha promoter independently of A2AR.
- The increase in HIF-1alpha mRNA due to NECA appears to occur after transcription, suggesting a post-transcriptional regulatory mechanism.
- Deletion of NF-kappaB-binding sites from the VEGF promoter does not alter VEGF promoter activity, indicating NF-kappaB's indirect role in VEGF transcription.
AI simplified